Implantable hearing devices

Combined hearing loss is an essential indication for implantable hearing systems. Depending on the bone conduction threshold, various options are available. Patients with mild sensorineural deafness usually benefit from transcutaneous bone conduction implants (BCI), while percutaneous BCI systems ar...

Descripción completa

Detalles Bibliográficos
Autor principal: Tisch, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738935/
https://www.ncbi.nlm.nih.gov/pubmed/29279724
http://dx.doi.org/10.3205/cto000145
_version_ 1783287789027065856
author Tisch, Matthias
author_facet Tisch, Matthias
author_sort Tisch, Matthias
collection PubMed
description Combined hearing loss is an essential indication for implantable hearing systems. Depending on the bone conduction threshold, various options are available. Patients with mild sensorineural deafness usually benefit from transcutaneous bone conduction implants (BCI), while percutaneous BCI systems are recommended also for moderate hearing loss. For combined hearing losses with moderate and high-grade cochlear hearing loss, active middle ear implants are recommended. For patients with incompatibilities or middle ear surgery, implants are a valuable and proven addition to the therapeutic options.
format Online
Article
Text
id pubmed-5738935
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher German Medical Science GMS Publishing House
record_format MEDLINE/PubMed
spelling pubmed-57389352017-12-26 Implantable hearing devices Tisch, Matthias GMS Curr Top Otorhinolaryngol Head Neck Surg Article Combined hearing loss is an essential indication for implantable hearing systems. Depending on the bone conduction threshold, various options are available. Patients with mild sensorineural deafness usually benefit from transcutaneous bone conduction implants (BCI), while percutaneous BCI systems are recommended also for moderate hearing loss. For combined hearing losses with moderate and high-grade cochlear hearing loss, active middle ear implants are recommended. For patients with incompatibilities or middle ear surgery, implants are a valuable and proven addition to the therapeutic options. German Medical Science GMS Publishing House 2017-12-18 /pmc/articles/PMC5738935/ /pubmed/29279724 http://dx.doi.org/10.3205/cto000145 Text en Copyright © 2017 Tisch This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Tisch, Matthias
Implantable hearing devices
title Implantable hearing devices
title_full Implantable hearing devices
title_fullStr Implantable hearing devices
title_full_unstemmed Implantable hearing devices
title_short Implantable hearing devices
title_sort implantable hearing devices
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738935/
https://www.ncbi.nlm.nih.gov/pubmed/29279724
http://dx.doi.org/10.3205/cto000145
work_keys_str_mv AT tischmatthias implantablehearingdevices

Ejemplares similares